Literature DB >> 9279881

Hepatic extraction of hexarelin, a new peptidic GH secretagogue, in the isolated perfused rat liver.

M Roumi1, S Marleau, M Boghen, M Nilsson, P Du Souich, H Ong.   

Abstract

PURPOSE: To assess the hepatic extraction of hexarelin (HEX), a novel peptidyl GH secretagogue, in the isolated perfused rat model and document the in vitro binding of HEX to plasma proteins using plasma from rats, dogs, pigs, and humans.
METHODS: Rat liver was perfused in situ using a recirculating system. The recirculating perfusate consisted of a Krebs Henseleit buffer containing 20% (v/v) prewashed bovine red blood cells, 1% albumin, and lg/L dextrose. Three HEX concentrations of 5, 50, and 500 ng/ml were examined. In vitro plasma binding was determined by the ultrafiltration method.
RESULTS: The disappearance rate constant (K), half-life (t1/2), clearance (Cl), and hepatic extraction ratio (E) were: K = 0.013-0.014 min-1, t1/2 = 45-55 min, Cl = 0.345-0.401 ml/min/g liver, and E = 19-21% for the different concentrations of HEX. A linear increase in AUC (270-24334 min pmol/ml) was observed with increasing concentrations. Binding of HEX to plasma proteins of rats, dogs, pigs, and humans was 68.7 +/- 0.8%, 78.7 +/- 0.6%, 67.3 +/- 0.7%, and 65.2 +/- 0.6% respectively. Plasma binding was concentration-independent in the range between 0.003-3 microM for the four species examined.
CONCLUSIONS: These results show that 1) the hepatic extraction of HEX is low, 2) the hepatic clearance is concentration independent up to 500 ng HEX/ml of perfusate, and 3) the plasma protein binding of HEX is significant over the dose range studied. HEX exhibits a low hepatic extraction ratio, allowing us to predict that its hepatic clearance may be limited upon HEX protein binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279881     DOI: 10.1023/a:1012193010009

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

Review 1.  The isolated perfused rat liver: conceptual and practical considerations.

Authors:  G J Gores; L J Kost; N F LaRusso
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

2.  Comparison of somatostatin-28 and somatostatin-14 clearance by the perfused rat liver.

Authors:  M Seno; Y Seino; Y Takemura; S Nishi; H Ishida; N Kitano; H Imura; T Taminato; S Matsukura
Journal:  Can J Physiol Pharmacol       Date:  1985-01       Impact factor: 2.273

3.  Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its pharmacokinetic studies.

Authors:  M Roumi; V Lenaerts; F Boutignon; P Wuthrich; R Deghenghi; M Bellemare; A Adam; H Ong
Journal:  Peptides       Date:  1995       Impact factor: 3.750

4.  Hexarelin, a potent GHRP analogue: interactions with GHRH and clonidine in young and aged dogs.

Authors:  S G Cella; V Locatelli; M Poratelli; V De Gennaro Colonna; B P Imbimbo; R Deghenghi; E E Müller
Journal:  Peptides       Date:  1995       Impact factor: 3.750

5.  Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.

Authors:  E Ghigo; E Arvat; L Gianotti; B P Imbimbo; V Lenaerts; R Deghenghi; F Camanni
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958

6.  A receptor in pituitary and hypothalamus that functions in growth hormone release.

Authors:  A D Howard; S D Feighner; D F Cully; J P Arena; P A Liberator; C I Rosenblum; M Hamelin; D L Hreniuk; O C Palyha; J Anderson; P S Paress; C Diaz; M Chou; K K Liu; K K McKee; S S Pong; L Y Chaung; A Elbrecht; M Dashkevicz; R Heavens; M Rigby; D J Sirinathsinghji; D C Dean; D G Melillo; A A Patchett; R Nargund; P R Griffin; J A DeMartino; S K Gupta; J M Schaeffer; R G Smith; L H Van der Ploeg
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

7.  GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats.

Authors:  R Deghenghi; M M Cananzi; A Torsello; C Battisti; E E Muller; V Locatelli
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

8.  GH releasing peptides--structure and kinetics.

Authors:  C Y Bowers
Journal:  J Pediatr Endocrinol       Date:  1993 Jan-Mar

9.  Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction.

Authors:  G J Gores; N F LaRusso; L J Miller
Journal:  Am J Physiol       Date:  1986-03

10.  A novel non-peptidyl growth hormone secretagogue.

Authors:  K Cheng; W W Chan; B Butler; L Wei; R G Smith
Journal:  Horm Res       Date:  1993
  10 in total
  1 in total

1.  Pharmacokinetics of amino acid phosphoramidate monoesters of zidovudine in rats.

Authors:  Heng Song; George W Griesgraber; Carston R Wagner; Cheryl L Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.